Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline

Oral and intravenous (IV) omadacycline formulations are approved in the United States for treating acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia in adults. Oral omadacycline bioavailability is 34.5%; similar exposures are obtained following 300 mg oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodvold, Keith A, Pai, Manjunath P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669312/
https://www.ncbi.nlm.nih.gov/pubmed/31367744
http://dx.doi.org/10.1093/cid/ciz309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669312/
https://www.ncbi.nlm.nih.gov/pubmed/31367744
http://dx.doi.org/10.1093/cid/ciz309

Ejemplares similares